(Q53434499)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22366723%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

title

Increasing O-GlcNAc slows neurodegeneration and stabilizes tau against aggregation (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22366723%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22366723%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

David J Vocadlo

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22366723%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

author name string

Scott A Yuzwa

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22366723%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

Xiaoyang Shan

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22366723%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

Thomas Clark

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22366723%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

Yuliya Skorobogatko

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22366723%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

Keith Vosseller

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22366723%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

publication date

26 February 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22366723%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

published in

Nature Chemical Biology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22366723%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

volume

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22366723%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22366723%20AND%20SRC:MED&resulttype=core&format=json

24 January 2020

page(s)

393-399

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22366723%20AND%20SRC:MED&resulttype=core&format=json

Neocortical neurofibrillary tangles correlate with dementia severity in Alzheimer's disease

24 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO.797

Association of missense and 5'-splice-site mutations in tau with the inherited dementia FTDP-17

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO.797

Distinct FTDP-17 missense mutations in tau produce tau aggregates and other pathological phenotypes in transfected CHO cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO.797

Neurofibrillary tangles, amyotrophy and progressive motor disturbance in mice expressing mutant (P301L) tau protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO.797

Tau suppression in a neurodegenerative mouse model improves memory function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO.797

Hyperphosphorylation induces self-assembly of tau into tangles of paired helical filaments/straight filaments

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO.797

Conformational change as one of the earliest alterations of tau in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO.797

Post-translational modifications of tau protein in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO.797

Targeting post-translational modifications on tau as a therapeutic strategy for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO.797

The microtubule-associated protein tau is extensively modified with O-linked N-acetylglucosamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO.797

Evidence of a balance between phosphorylation and O-GlcNAc glycosylation of Tau proteins--a role in nuclear localization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO.797

O-GlcNAcylation regulates phosphorylation of tau: a mechanism involved in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO.797

Dynamic glycosylation of nuclear and cytosolic proteins. Cloning and characterization of a unique O-GlcNAc transferase with multiple tetratricopeptide repeats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO.797

O-Linked GlcNAc transferase is a conserved nucleocytoplasmic protein containing tetratricopeptide repeats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO.797

Dynamic O-glycosylation of nuclear and cytosolic proteins: cloning and characterization of a neutral, cytosolic beta-N-acetylglucosaminidase from human brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO.797

Dynamic O-GlcNAcylation of the small heat shock protein alpha B-crystallin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO.797

A potent mechanism-inspired O-GlcNAcase inhibitor that blocks phosphorylation of tau in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO.797

Abnormalities of Energy Metabolism in Alzheimer's Disease Studied with PETa

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO.797

Cerebral metabolic changes accompanying conversion of mild cognitive impairment into Alzheimer's disease: a PET follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO.797

Functional screening of Alzheimer pathology genome-wide association signals in Drosophila

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO.797

Brain glucose transporters, O-GlcNAcylation and phosphorylation of tau in diabetes and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO.797

Dysregulation of the nutrient/stress sensor O-GlcNAcylation is involved in the etiology of cardiovascular disorders, type-2 diabetes and Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO.797

Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's disease – is this type 3 diabetes?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO.797

Concurrent alterations of O-GlcNAcylation and phosphorylation of tau in mouse brains during fasting

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO.797

Reduced O-GlcNAcylation links lower brain glucose metabolism and tau pathology in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO.797

Glucose metabolism and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO.797

Enrichment and site mapping of O-linked N-acetylglucosamine by a combination of chemical/enzymatic tagging, photochemical cleavage, and electron transfer dissociation mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO.797

Mapping O-GlcNAc modification sites on tau and generation of a site-specific O-GlcNAc tau antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO.797

Elevation of Global O-GlcNAc in rodents using a selective O-GlcNAcase inhibitor does not cause insulin resistance or perturb glucohomeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO.797

Efficacy of a novel, orally active GSK-3 inhibitor 6-Methyl-N-[3-[[3-(1-methylethoxy)propyl]carbamoyl]-1H-pyrazol-4-yl]pyridine-3-carboxamide in tau transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO.797

An inhibitor of tau hyperphosphorylation prevents severe motor impairments in tau transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO.797

Assembly of tau in transgenic animals expressing P301L tau: alteration of phosphorylation and solubility

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO.797

Identification of O-GlcNAc sites within peptides of the Tau protein and their impact on phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO.797

Tau nitration occurs at tyrosine 29 in the fibrillar lesions of Alzheimer's disease and other tauopathies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO.797

Caspase activation precedes and leads to tangles

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO.797

Triggers of full-length tau aggregation: a role for partially folded intermediates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO.797

Assembly of microtubule-associated protein tau into Alzheimer-like filaments induced by sulphated glycosaminoglycans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO.797

Rapid assembly of Alzheimer-like paired helical filaments from microtubule-associated protein tau monitored by fluorescence in solution

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO.797

Effects of different anti-tau antibodies on tau fibrillogenesis: RTA-1 and RTA-2 counteract tau aggregation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO.797

Structural insights into mechanism and specificity of O-GlcNAc transferase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO.797

TAK1-binding protein 1 is a pseudophosphatase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO.797

The core trisaccharide of an N-linked glycoprotein intrinsically accelerates folding and enhances stability

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO.797

Protein native-state stabilization by placing aromatic side chains in N-glycosylated reverse turns

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO.797

Anthraquinones inhibit tau aggregation and dissolve Alzheimer's paired helical filaments in vitro and in cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCHEMBIO.797

Purification and characterization of an O-GlcNAc selective N-acetyl-beta-D-glucosaminidase from rat spleen cytosol.

21 January 2018

1 reference

12 December 2020

Clinical deterioration in probable Alzheimer's disease correlates with progressive metabolic impairment of association areas.

1 reference

12 December 2020

Impaired insulin and insulin-like growth factor expression and signaling mechanisms in Alzheimer's disease--is this type 3 diabetes?

1 reference

12 December 2020

Free fatty acids stimulate the polymerization of tau and amyloid beta peptides. In vitro evidence for a common effector of pathogenesis in Alzheimer's disease.

1 reference

12 December 2020

The potential role of tau protein O-glycosylation in Alzheimer's disease

1 reference

12 December 2020

Effects of frontotemporal dementia FTDP-17 mutations on heparin-induced assembly of tau filaments

1 reference

12 December 2020

Discovery of a metabolic pathway mediating glucose-induced desensitization of the glucose transport system. Role of hexosamine biosynthesis in the induction of insulin resistance

1 reference

12 December 2020